期刊文献+

VEGF在中国三阴性乳腺癌患者中的表达及与其临床病理特征关系的meta分析 被引量:3

Expression of vascular endothelial growth factor in patients with triple negative breast cancer in China and its relation to clinicopathologic features: a meta-analysis
原文传递
导出
摘要 目的系统评价血管内皮生长因子(VEGF)在中国三阴性乳腺癌(TNBC)患者中的表达情况以及其阳性表达与TNBC患者临床病理特征的关系。方法通过中国知网、万方数据库、维普、中国生物医学数据库、超星Medalink和Pub Med数据库检索已发表的有关关于中国TNBC患者的相关文献资料,由2名研究者按照纳入与排除标准独立筛选文献、提取资料和文献评价,然后使用Rev Man 5.3软件进行meta分析。结果本研究纳入11篇相关文献共1 838例患者,其中TNBC患者750例,非TNBC患者1 088例。meta分析结果显示,VEGF蛋白表达阳性率在TNBC患者中明显高于非TNBC患者[OR=2.64,95%CI(2.14,3.26),P<0.000 01]。在TNBC患者中,VEGF蛋白表达阳性率在淋巴结(+)患者中明显高于淋巴结(–)患者[OR=0.30,95%CI(0.14,0.46),P=0.000 2]、在Ⅲ–Ⅳ期患者中明显高于Ⅰ–Ⅱ期患者[OR=0.43,95%CI(0.29,0.62),P<0.000 01],其与TNBC患者的年龄[OR=0.80,95%CI(0.54,1.19),P=0.27]和肿瘤大小[OR=0.84,95%CI(0.53,1.33),P=0.46]无关。结论 VEGF蛋白在TNBC患者中呈高表达,有望成为其治疗的新靶点;且其蛋白阳性表达与TNBC患者的阳性淋巴结及TNM分期晚有关,其可能与TNBC患者的预后有一定的关系。 Objective To systematically evaluate expression of vascular endothelial growth factor (VEGF) protein in triple negative breast cancer (TNBC) and analyze its correlation between positive expression of VEGF protein and clinicopathologic features of patient with TNBC. Methods The published literatures relevant VEGF protein expression in TNBC and its relation to clinicopathologic features of patient with TNBC in China were retrieved by means of CNKI, Wanfang, VIP, China Biomedical, Chaoxing Medalink, PubMed databases, and other search tools. The literatures were independently filtered, extracted, and assessed by two reviewers according to the inclusion criteria and exclusion criteria. The meta-analysis was conducted by using RevMan 5.3 software. Results A total of 11 literatures were included and involved I 838 patients (750 patients in the TNBC group and 1 088 patients in the non-TNBC group). The results of meta- nalysis showed that the positive expression of VEGF protein in the TNBC group was significantly higher than that in the non-TNBC group [ OR=2.64, 95%CI (2.14, 3.26), P〈0.000 01 ), which was significantly increased in the TNBC patients with positive lymph node or stage Ⅲ-Ⅳ as compared with the negative lymph node or stage Ⅰ - Ⅱ [OR=0.30, 95% CI (0.14, 0.46), P=0.000 2; OR=0.43, 95% CI (0.29, 0.62), P〈0.000 011. However, the positive expression of VEGF protein was no associated with the age of patients with TNBC or tumor size (P〉0.05). Conclusions VEGF highly expresses in TNBC and it is expected to be a new therapeutic target. Positive expression of VEGF protein is related to positive lymph node and late TNM stage, and it might be associated with prognosis of patient with TNBC.
出处 《中国普外基础与临床杂志》 CAS 2017年第8期992-999,共8页 Chinese Journal of Bases and Clinics In General Surgery
关键词 三阴性乳腺癌 血管内皮生长因子 META分析 triple negative breast cancer vascular endothelial growth factor meta-analysis
作者简介 通信作者:地力木拉提&#183;艾斯木吐拉,Email:2499156828@qq.com
  • 相关文献

参考文献10

二级参考文献127

  • 1李宝江,朱志华,王军业,侯景辉,赵进明,张蓬原,姚广裕,王曦,龙浩,杨名添,戎铁.Ki67、P53、VEGF和C-erbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J].癌症,2004,23(10):1176-1179. 被引量:126
  • 2王深明,朱彩霞,黎志勋,王劲松,林颖.乳腺癌血行转移与血管生成相关因子相关性研究[J].中华实验外科杂志,2005,22(5):524-526. 被引量:17
  • 3赵卫红,徐兵河,张频,李青,赵龙妹,孙燕.乳腺癌合并脉管瘤栓的临床病理特点及预后因素分析[J].中华肿瘤杂志,2007,29(2):137-140. 被引量:14
  • 4Schoppmann SF, Bayer G, Aumayr K,et al. Prognostic value of lyrnphangiogenesis and lymphovascular invasion in invasive breast cancer[ J]. Ann Surg,2004, 240:306-312.
  • 5Solow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors [J]. Cancer, 2000, 89(12) :2637-2645.
  • 6Miglietta A, Toselli M, Ravarino N,et at. COX-2 expression in human breast carcinomas: colxelation with clinieopathological fea- tures and prognostic molecular markers[ J]. Expert Opin Ther Tar- gets, 2010,14(7) :655-664.
  • 7LeeSJ, Lee SY, JeonEON HS, et al. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer [ J ]. Cancer Epidermal Biomarkers Prey, 2005,14 (3) :571-575.
  • 8Guo GL, Yang GL, Li ZY, et al. The etfeet of cyelooxygenase-2 on lymphangiogenesis in breast cancer[J]. Zhonghua Wai Ke Za Zhi, 2008,46(2) :132-135.
  • 9Linderholm BK, Hellborg H, Johansson U, et al. Significantly higher levels of vaseular endothelial growth factor ( VEGF ) and shorter survival times for patients with primary operable triple-ncg- ative breast eaneer[J]. Ann Oncol,2009,20(10) :1639-1646.
  • 10Freres P, Collignon J, Gennigens C, et al. "Triple negative" breast cancer[J]. Rev Med Liege, 2010,65 (3) :120-126.

共引文献915

同被引文献29

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部